Skip to content
Open Data Finder
Open Government Canada

Notice: Policy on Bioequivalence Standards for Highly Variable Drug Products

Published by Health Canada | Santé Canada

About this dataset

This Notice serves to inform sponsors of drug submissions pursuant to Division C.08 of the Food and Drug Regulations (that is [i.e.], new drug and abbreviated new drug submissions) of changes in Health Canada's comparative bioavailability requirements for drug products which exhibit large pharmacokinetic within-subject variation in extent of absorption, as measured by area under the concentration versus time curve (AUC).

Notice: Policy on Bioequivalence Standards for Highly Variable Drug Products · Open Data Finder